Literature DB >> 21392878

Methotrexate therapy followed by suction curettage followed by Foley tamponade for caesarean scar pregnancy.

Tao Jiang1, Guipeng Liu, Ling Huang, Haining Ma, Shulan Zhang.   

Abstract

OBJECTIVES: Caesarean scar pregnancy (CSP) is a very rare and dangerous form of pregnancy because of the increased risk of rupture and excessive hemorrhage. There is currently no consensus on the treatment. We studied if methotrexate (MTX) therapy followed by suction curettage followed by Foley tamponade was a viable treatment for patients with CSP. STUDY
DESIGN: Forty-five patients with CSP in our hospital received a single dose of 50mg/m(2) MTX by intramuscular injection. If gestational cardiac activity was seen on transvaginal ultrasound, local injection of MTX was given. After 7 days, suction curettage was performed to remove the retained products of conception and blood clot (CSP mass) under transabdominal sonography (TAS) guidance. After the suction curettage, a Foley catheter balloon was placed into the isthmic portion of cervix.
RESULTS: Forty-two subjects were successfully treated and 3 subjects failed treatment. The mean estimated blood loss of all 45 patients was 706.89 ± 642.08 (100-3000)ml. The resolution time of the serum β-hCG was 20.62 ± 5.41 (9-33) days. The time to CSP mass disappearance was 12.57 ± 4.37 (8-25) days.
CONCLUSIONS: MTX administration followed by suction curettage followed by Foley tamponade was an effective treatment for caesarean scar pregnancy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392878     DOI: 10.1016/j.ejogrb.2011.01.016

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Evaluation of the treatment of high intensity focused ultrasound combined with suction curettage for exogenous cesarean scar pregnancy.

Authors:  Lin Mu; Huifang Weng; Xiaoyun Wang
Journal:  Arch Gynecol Obstet       Date:  2022-03-18       Impact factor: 2.493

2.  Evaluation of treatment of previous cesarean scar pregnancy with methotrexate: a systematic review and meta-analysis.

Authors:  Nader Salari; Mohsen Kazeminia; Shamarina Shohaimi; Anis Al-Dawlah Nankali; Masoud Mohammadi
Journal:  Reprod Biol Endocrinol       Date:  2020-11-09       Impact factor: 5.211

3.  Definition and sonographic reporting system for Cesarean scar pregnancy in early gestation: modified Delphi method.

Authors:  I P M Jordans; C Verberkt; R A De Leeuw; C M Bilardo; T Van Den Bosch; T Bourne; H A M Brölmann; M Dueholm; W J K Hehenkamp; N Jastrow; D Jurkovic; A Kaelin Agten; R Mashiach; O Naji; E Pajkrt; D Timmerman; O Vikhareva; L F Van Der Voet; J A F Huirne
Journal:  Ultrasound Obstet Gynecol       Date:  2022-04       Impact factor: 8.678

4.  Clinical and ultrasound parameters in prediction of excessive hemorrhage during management of cesarean scar pregnancy.

Authors:  Ting Gui; Ping Peng; Xinyan Liu; Li Jin; Weilin Chen
Journal:  Ther Clin Risk Manag       Date:  2017-06-30       Impact factor: 2.423

5.  Successful management of cesarean scar pregnancy with vacuum extraction under ultrasound guidance.

Authors:  Görker Sel; Sadun Sucu; Müge Harma; Mehmet İbrahim Harma
Journal:  Acute Med Surg       Date:  2018-08-13

6.  Cesarean Scar Pregnancy Successfully Managed to Term: When the Patient Is Determined to Keep the Pregnancy.

Authors:  Ranko Kutlesic; Marija Kutlesic; Predrag Vukomanovic; Milan Stefanovic; Danka Mostic-Stanisic
Journal:  Medicina (Kaunas)       Date:  2020-09-24       Impact factor: 2.430

7.  Combination of medical and surgical management in successful treatment of caesarean scar pregnancy: a case report series.

Authors:  Anda Pristavu; Angela Vinturache; Elena Mihalceanu; Radu Pintilie; Mircea Onofriescu; Demetra Socolov
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-13       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.